| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
3e-13 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-11 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |